Thank you to Stanford Medicine for highlighting our first #TIL patient infused with commercial lifileucel and to our patient to giving a little insight into his journey. #2024YearOfTheTIL Stanford Cancer Institute

Thanks for sharing our paper on the very low risk of T cell malignancies driven by insertional mutagenesis in a paediatric/young adult CART setting. Impt to contrast with the non-negligible risk of secondary myeloid malignancies seen with CART as with any anti-leukaemic therapy…

Salute the ultimate sacrifice of the Air Warrior Killed in Action today. Heart goes out to his family. Also salute the other five Indian Air Force (Indian Air Force) personnel who have sustained Gun Shot Wounds. We stand with you, the nation stands with you. Your pain is our pain 🙏
🇮🇳

Wonderful news- congratulations 💐💐💐
And so well deserved👍🏻👏🏻👏🏻👏🏻
Very very proud
More power to you👍🏻

Celebrating Excellence: Dr. Crystal Mackall's work has advanced understanding of fundamental immunology and translated this understanding for the treatment of human disease with a major focus on children’s cancers.

>> Read her story here: tinyurl.com/4874esyz

SIOP Women Leaders in Paediatric Oncology Network

ImPaCCT Foundation, TMC organised the biggest sports event for 250 children with Cancer! This was done in partnership with Duhita Foundation! Hear our dignatories, staff and volunteers address the audience!
#sports #childhoodcancer

Congratulations JenniferGeel 💐💐💐
SIOP-Africa will do great with you at the helm!
More power to you 👍🏻
SIOP International SIOP Global Health Young LMIC SIOP Women Leaders in Paediatric Oncology Network Young SIOP SIOP Asia PHO INDIA

Second Gene therapy for Hemophilia B approved in the US.

- AAVRh74var
- Dose -5 x 1011 vg/kg of body weight.
- Almost 50% patients developed transaminits
- Almost 50% needed steroids for it post Gene therapy
- No reports of malignancy Clincial trials.
- Price : 3.5 million per…

Ready to have some fun with your abstract?

Each yr 1000s of families seek a place to stay in Mumbai for their child’s cancer treatment at Tata Memorial Hospital Many abandon treatment due to lack of a place to stay. Ogilvy partnered with St. Jude India ChildCare Centres to highlight this issue

youtu.be/j_k7SJu97gM?si…

Pls watch n share Sidin

Congratulations
This is the way forward, out of necessity, Yes- but could well be the preferred option for us 👍🏻

Pilot data supporting a role for maintenance chemotherapy following early B cell recovery after CART for B-ALL in transplant ineligible patients. Needs longer follow up and prospective study. Thanks to Maria Gabelli and macamoe

Maintenance therapy for early loss of B-cell aplasia after anti-CD19 CAR T-cell therapy
ow.ly/bq3m50RmqWc #immunobiologyandimmunotherapy #lymphoidneoplasia

Let us ensure that more children are protected from vaccine preventable disease.
@NepasOfficial #IPAWorldImmunizationWeek2024 #IPAWIW2024 #mohpnepal

My oped in todays ⁦The Indian Express⁩ on the Supreme Courts recent strong words on controlling private health care costs.Few key points ….

who are we?
ACADEMICS!
and what do we do?
DOWNLOAD ARTICLES!
and then what do we do?
DOWNLOAD ARTICLES!

The Women Leaders in Paediatric Oncology (WLPO) Network are sharing the stories, personal influences & difficult lessons learnt from Women in #PaediatricOncology to inspire the next generation of #WomenLeadersInMedicine .

Meet Dr. Kusuma Kumary: loom.ly/qO9GVh0

We celebrate women leaders in #PaediatricOncology and honor Dr. KUSUMA KUMARY who made advanced cancer treatment accessible to underprivileged children across the Kerala region of India.

INPHOG
#WomenInMedicine
#WomenWhoLead
@worldSIOP

siop-online.org/women

🔑 At SIOP, we believe that networking is key.

🗨️ The congress is the place to meet new colleagues, to explore new opportunities and to develop international collaborations.

Be part of the community and join us in Hawaii or online 👉 bit.ly/3k2cgmr

#SIOPcongress

'Asha' means hope. FDA Oncology's Project Asha aims to increase oncology clinical trial access in India. India accounts for ~20% of the global population yet only 1.5% of global trials are conducted there. Lead: Geetika Srivastava MD MSPH
fda.gov/about-fda/onco…

#OCEProjectAsha